Skip to main content

NWF Advisory Services Inc.

Position in CTSO — Cytosorbents Corp

CIK 2045735 Los Angeles, CA

Position in CTSO

as of Mar 31, 2026 · filed May 4, 2026
Position Value
$58,942
-$7,602 QoQ
Shares Held
104,139
0.0% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in CTSO Over Time

Shares Held

Position Value (USD)

Derivatives in CTSO

reported options exposure · as of Jun 30, 2024
CallValue
$1,757
CallShares
2,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

NWF Advisory Services Inc. holds $2,102,040 across 4 Medical Devices names. CTSO ranks #4 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 CTSO
Cytosorbents Corp
This page
104,139 $58,942

All Filings in CTSO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $58,942 104,139
2025-12-31 $66,544 104,139
2025-09-30 $97,265 104,139
2025-06-30 $133,297 104,139
2025-03-31 $104,139 104,139
2024-09-30 $100,200 66,800
2024-06-30 $1,757 2,500
2024-06-30 $39,930 56,800
2024-03-31 $53,960 56,800
2024-03-31 $2,375 2,500
2023-12-31 $60,717 54,700
2023-09-30 $5,640 3,000
2023-09-30 $91,086 48,450
2023-06-30 $159,575 44,450
2023-06-30 $17,950 5,000
2023-03-31 $149,796 44,450
2023-03-31 $16,850 5,000